Heart transplant patients get hepatitis c cure hope
Disease control
Completed
This study looked at whether a 12-week course of glecaprevir/pibrentasivir can safely cure hepatitis C in heart transplant patients who got the virus from infected donors. Fifty adults on the transplant waitlist were enrolled, and those who received a hepatitis C-positive heart w…
Sponsor: Sentara Norfolk General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC